Global Pharmaceuticals & Biotech Most Popular Stocks

Corcept Therapeutics

Market Cap: US$8.8b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Haisco Pharmaceutical Group

Market Cap: CN¥61.3b

Researches, develops, manufactures, and sells pharmaceutical products in China.

Caris Life Sciences

Market Cap: US$8.6b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Grifols

Market Cap: €7.2b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Sichuan Kelun Pharmaceutical

Market Cap: CN¥59.8b

Researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China.

Financière de Tubize

Market Cap: €7.1b

Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.

Pharmaron Beijing

Market Cap: CN¥58.5b

Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

Avantor

Market Cap: US$8.2b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

RemeGen

Market Cap: HK$63.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.

TransThera Sciences (Nanjing)

Market Cap: HK$63.4b

TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.

Revolution Medicines

Market Cap: US$8.1b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, sells, and import/export of pharmaceuticals products worldwide.

Bio-Techne

Market Cap: US$8.0b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Krka d. d

Market Cap: €6.7b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

Jazz Pharmaceuticals

Market Cap: US$7.8b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Imeik Technology DevelopmentLtd

Market Cap: CN¥54.6b

Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.

Bio-Rad Laboratories

Market Cap: US$7.5b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Alkem Laboratories

Market Cap: ₹660.6b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Stevanato Group

Market Cap: US$7.4b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Charles River Laboratories International

Market Cap: US$7.4b

Charles River Laboratories International, Inc.

Abbott India

Market Cap: ₹642.0b

Operates as a pharmaceutical company in India.

Regencell Bioscience Holdings

Market Cap: US$7.2b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

Aurobindo Pharma

Market Cap: ₹638.0b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

Chongqing Zhifei Biological Products

Market Cap: CN¥50.3b

Chongqing Zhifei Biological Products Co., Ltd.

ALK-Abelló

Market Cap: DKK 44.9b

Operates as an allergy solutions company in Europe, North America, and internationally.

Repligen

Market Cap: US$7.0b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Hangzhou Tigermed Consulting

Market Cap: CN¥49.7b

Provides contract research organization services in the People’s Republic of China and internationally.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥49.6b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

Changchun High-Tech Industry (Group)

Market Cap: CN¥49.4b

Researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China.

XtalPi Holdings

Market Cap: HK$53.3b

An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.

H. Lundbeck

Market Cap: DKK 43.1b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Gan & Lee Pharmaceuticals

Market Cap: CN¥47.4b

A biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China.

Beijing Tongrentang

Market Cap: CN¥46.8b

Engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally.

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥46.5b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Glenmark Pharmaceuticals

Market Cap: ₹571.7b

Develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally.

Rhythm Pharmaceuticals

Market Cap: US$6.4b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.